Article Details

Aimmune Therapeutics Inc (AIMT) Given Consensus Recommendation of “Hold” by Analysts

Retrieved on: 2019-06-09 16:41:45

Tags for this article:

Click the tags to see associated articles and topics

Aimmune Therapeutics Inc (AIMT) Given Consensus Recommendation of “Hold” by Analysts. View article details on HISWAI:

Excerpt

<div>Finally, <b>Man Group plc</b> purchased a new stake in shares of Aimmune Therapeutics during the first quarter valued at approximately $1,649,000.</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up